New treatment method for reducing suicidality after a crisis
A Randomized Controlled Study on the Effectiveness of the Suicidal Crisis Intervention (SCI)
This study is testing a new short-term treatment for people who have recently tried to harm themselves to see if it can help reduce feelings of hopelessness and improve support from family and friends.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 390 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 12 sites (Beernem and 11 other locations) |
| Trial ID | NCT05638204 on ClinicalTrials.gov |
What this trial studies
This project aims to evaluate the effectiveness of the Suicidal Crisis Intervention (SCI), a short-term treatment designed for individuals who have recently experienced a suicide attempt or suicidal crisis. The intervention focuses on reducing suicidality and addressing related factors such as hopelessness and interpersonal needs. The treatment involves the participation of relatives to enhance social support and aims to create a structured care plan that fosters hope and continuity of care. The study will assess both the feasibility of SCI and the experiences of patients and their close ones.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have recently attempted suicide or are in a suicidal crisis and can communicate in Dutch.
Not a fit: Patients with cognitive impairments, psychotic disorders, or those unsuitable for individual therapy may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the risk of future suicide attempts and improve overall mental health outcomes for patients.
How similar studies have performed: While there is limited evidence-based short-term treatment specifically for this population in Flanders, similar interventions have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria Patient: * After a suicide attempt or suicidal crisis * ≥ 18 years * Availability of a smartphone, tablet and/or computer with internet access, * Dutch-speaking. Exclusion Criteria Patient: * Limited comprehension, cognitive impairment * Psychotic disorder * Unsuitable for individual therapy * Receiving other forms of care is not an exclusion criterion. Inclusion Criteria Close one: * close one of the patient * ≥ 18 years * Dutch- speaking
Where this trial is running
Beernem and 11 other locations
- Psychiatrisch Centrum Sint Amandus (incl. Mobiel Crisis Team) — Beernem, Belgium (Recruiting)
- Medisch Centrum St. Jozef — Bilzen, Belgium (Recruiting)
- Mobiel Crisis Team zorggroep Multiversum — Boechout, Belgium (Recruiting)
- Openbaar Psychiatrisch Zorgcentrum Geel — Geel, Belgium (Recruiting)
- UZ Gent — Ghent, Belgium (Recruiting)
- AZ Groeninge (incl. Mobiel Crisis Team Kortrijk) — Kortrijk, Belgium (Recruiting)
- Psychiatrisch Ziekenhuis Heilige Familie Kortrijk — Kortrijk, Belgium (Recruiting)
- Psychiatrisch Centrum Ariadne — Lede, Belgium (Recruiting)
- Openbaar Psychiatrisch Zorgcentrum Rekem — Rekem, Belgium (Recruiting)
- Algemeen Ziekenhuis Glorieux — Ronse, Belgium (Recruiting)
- Psychiatrisch Ziekenhuis Sint Lucia (incl. Mobiel Team Acute Zorgen) — Sint-Niklaas, Belgium (Recruiting)
- Bethanië GGZ (incl. mobiel crisis team SARA Het Veer) — Zoersel, Belgium (Recruiting)
Study contacts
- Principal investigator: Gwendolyn Portzky, Phd — University Ghent
- Study coordinator: Eva De Jaegere, Msc
- Email: eva.dejaegere@ugent.be
- Phone: +32 (0)9 332.07.75
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.